Table 1.
Baseline characteristics and symptoms of 172 patients who were investigated in this study.
| Characteristics and symptoms | All Patients (n = 172) | ICU care (n = 25) | hospitalized without need to ICU care (n = 36) | Non-hospitalized candidates which was checked by RT-PCR or CT-Scan (n = 75) | Normal candidates with non-involvement to COVID-19 (n = 36) |
|---|---|---|---|---|---|
| Characteristics | |||||
| Age | 46.3 (21–76) | 53.7 (41–65) | 47 (21–76) | 45.3 (24–58) | 39.1 (22–60) |
| Sex | |||||
| Female | 67 (39%) | 8 (32%) | 12 (33%) | 32 (43%) | 15 (42%) |
| Male | 105 (61%) | 17 (68%) | 24 (67%) | 43 (57%) | 21 (58%) |
| Race | White | White | White | White | White |
| Current Smoking | 28 (16%) | 0 | 2 (6%) | 19 (25%) | 7 (19%) |
| Any comorbidity | |||||
| Diabetes | 30 (17%) | 9 (36%) | 7 (19%) | 12 (16%) | 2 (6%) |
| Hypertension | 14 (8%) | 6 (24%) | 3 (8%) | 5 (7%) | 0 |
| pulmonary disease | 2 (1%) | 2 (8%) | 0 | 0 | 0 |
| Cardiovascular disease | 11 (6%) | 5 (20%) | 3 (8%) | 2 (3%) | 1 (3%) |
| Chronic liver disease | 6 (3%) | 1 (4%) | 2 (6%) | 3 (4%) | 0 |
| Hypothyroidism | 21 (12%) | 3 (12%) | 2 (6%) | 13 (17%) | 3 (8%) |
| Hyperthyroidism | 7 (4%) | 1 (4%) | 0 | 6 (8%) | 0 |
| Immune deficiency disease | 1 (1%) | 1 (4%) | 0 | 0 | 0 |
| Symptoms | |||||
| Fever | 107 (62%) | 25 (100%) | 34 (94%) | 42 (56%) | 6 (17%) |
| Cough | 84 (49%) | 23 (92%) | 31 (86%) | 25 (34%) | 5 (14%) |
| Myalgia or fatigue | 75 (44%) | 22 (88%) | 29 (81%) | 22 (29%) | 2 (6%) |
| Dyspnoea | 72 (42%) | 24 (96%) | 28 (78%) | 18 (24%) | 2 (6%) |
| Diarrhoea | 4 (2%) | 0 | 2 (6%) | 2 (3%) | 0 |
| Vomit | 11 (6%) | 2 (8%) | 2 (6%) | 7 (9%) | 0 |
| Headache | 47 (27%) | 5 (20%) | 12 (33%) | 27 (36%) | 3 (8%) |
| Lack of appetite | 80 (47%) | 22 (88%) | 31 (86%) | 25 (33%) | 2 (6%) |
| Vertigo | 6 (3%) | 2 (8%) | 4 (11%) | 0 | 0 |
| Chest pain | 14 (8%) | 4 (16%) | 7 (19%) | 3 (4%) | 0 |
| Sore throat | 36 (21%) | 1 (4%) | 5 (14%) | 25 (33%) | 5 (14%) |
| Haemoptysis | 2 (1%) | 1 (4%) | 1 (3%) | 0 | 0 |